Find Academic Supervisors

• Neurodegeneration
• Disease model development
• Parkinson's disease
• +4 more

John Haynes is a Senior Lecturer at Monash University's Faculty of Pharmacy and Pharmaceutical Sciences, leading the Stem Cell Biology group. He is affiliated with the Monash Institute of Pharmaceutical Sciences and contributes to the Medicinal Chemistry and Drug Action division. His research focuses on neurodegenerative diseases, particularly Parkinson's and Alzheimer's, leveraging stem cell models and drug discovery approaches. Haynes teaches courses in renal physiology, pharmacology, neurodegeneration, and diuretic action. Research interests include disease model development, inflammation mechanisms, and translational therapies. Notably, his work explores stem cell-derived models for neurodegenerative disorders and employs molecular dynamics to enhance drug efficacy. He has led or co-led 18 research projects since 2002, funded by organizations like NHMRC and ARC, focusing on topics such as Alport syndrome, microglial progenitors, and dopaminergic neuron maturation. His publications span 2023 to 1988, with recent work emphasizing stem cell differentiation, neuronal maturation, and stress-Alzheimer's interactions. Haynes has engaged in academic activities, including submissions to government committees and media contributions, such as a 2019 feature on functional food validation tools. He actively supervises PhD students in neurodegeneration projects.

Nicola Hamilton-WhitakerView profile

Senior Lecturer

• Neuroscience
• Neuroinflammation
• White Matter Diseases
• +5 more

Dr. Nicola Hamilton-Whitaker is a Senior Lecturer at King's College London, affiliated with the Wolfson Sensory, Pain and Regeneration Centre (Wolfson SPaRC) within the School of Neuroscience. Her research focuses on white matter diseases such as Multiple Sclerosis and Small Vessel Disease, investigating cellular communication mechanisms in brain function using advanced techniques like electrophysiology and imaging. She leads the Hamilton Lab, which explores interactions between neurons, glial cells, immune cells, and vasculature in disease models. Her work contributes to understanding receptor-mediated cellular communication and myelin damage under ischemic conditions. Collaborations include partnerships with University College London (UCL) and other institutions. Key projects funded by MRC and ELA investigate white matter function, TRP channel roles, and neurodegenerative therapies. She has authored over 22 peer-reviewed articles, with notable contributions on TRPA1 channels, myelination dynamics, and microglial physiology. Dr. Hamilton-Whitaker's research aligns with UN Sustainable Development Goals, particularly those addressing health and well-being. Her lab's work bridges basic science to translational medicine, aiming to develop therapies for neurological disorders.

Suzanne van der VeldtView profile

Assistant Professor

• Neuroscience
• Behavioural Neuroscience
• Anxiety Disorders
• +5 more

Suzanne van der Veldt serves as an Assistant Professor at the University of Groningen's Faculty of Science and Engineering within the Groningen Institute for Evolutionary Life Sciences (GELIFES), specializing in the behavioural neuroscience cluster. Her research focuses on how the brain distinguishes between safe and threatening contexts, particularly examining failures in this process that lead to anxiety disorders, PTSD, and other fear-related conditions. PhD in Neuroscience from McGill University (2016-2021) as a Vanier Canada Graduate Scholar Postdoctoral fellowship at Université de Montréal and CHU Sainte-Justine (2021-2025) supported by CIHR and FRQS fellowships MSc in European Master in Neuroscience (Neurasmus program) (2013-2015) Her research integrates traditional laboratory approaches with innovative studies of free-roaming mice in semi-naturalistic environments to bridge the gap between controlled experiments and real-world complexity. She specializes in the septohippocampal system, employing cutting-edge techniques including multi-region neural recordings, cell-type specific manipulations, and miniaturized calcium imaging in freely behaving animals. Her work examines how neural circuits assign emotional value to places and experiences, with particular attention to sex differences in emotional processing and vulnerability to anxiety disorders. Analysis of her publication record reveals a consistent focus on hippocampal-septal circuitry, with significant contributions to understanding spatial memory coding, neural oscillations (particularly theta and gamma rhythms), and the neural basis of fear conditioning. Her research increasingly incorporates sex as a biological variable and examines circuit dysfunctions in psychiatric conditions. Vanier Canada Graduate Scholarship (prestigious Canadian doctoral award) CIHR Fellowship (Canadian Institutes of Health Research) FRQS Fellowship (Fonds de recherche du Québec - Santé) Dr. van der Veldt leads the Van der Veldt Lab for Behavioural Neuroscience, which investigates emotional processing through innovative approaches combining circuit neuroscience with ethologically relevant behavioral paradigms. Her lab receives funding through tenure-track mechanisms at the University of Groningen and previously secured competitive fellowships during her postdoctoral training. The lab actively collaborates with international neuroscience groups, particularly with researchers at McGill University and Université de Montréal.

• Neuropharmacology
• Neuroscience
• Neurodegenerative Diseases
• +8 more

Professor Keith Murphy is a leading academic at University College Dublin , affiliated with the School of Biomolecular and Biomedical Science and the Conway Institute . As head of the UCD Neurotherapeutics Research Group , he pioneers work on drug targets for neurological disorders. Professor of Neuropharmacology (2018–present) Co-Director, UCD Centre for Applied Neuroscience (2015–present) Theme Leader for Neuroscience Research (2011–present) His research spans drug addiction , schizophrenia , multiple sclerosis , and memory consolidation , utilizing animal models , in vivo gene editing , and proteomic analysis . Recent work on cocaine-induced neurodevelopmental damage and midkine's role in memory demonstrates his focus on synaptic plasticity mechanisms. Key scientific contributions include: 2006: Rafaelsen Scholarship for neuropharmacology research 2016: Discovery of REST as hypoxia-responsive repressor 2025: Groundbreaking prenatal cocaine organoid study As an educator , he coordinated modules like Advanced CNS Pharmacology and Professional Career Development , mentoring future biomedical scientists. Current grants include SFI funding (2024–2027) for GDF-15/GFRAL signaling research in neuroprotection.

Johanne Egge RinholmView profile

Associate Professor

• Neuroscience
• Neurophysiology
• Cell Biology
• +3 more

Johanne Egge Rinholm is an Associate Professor at the University of Oslo's Section of Physiology. Her research focuses on oligodendrocyte biology, myelin physiology, and metabolic regulation in the nervous system, particularly investigating lactate signaling, mitochondrial dynamics, and oxidative stress. Institution: University of Oslo Academic Rank: Associate Professor Research Interests include: brain metabolism, ischemic brain injury, mitochondrial function in oligodendrocytes, neuroglial interactions, and lactate receptor (HCAR1) mechanisms. She has pioneered studies on lactate's role in neuroprotection and angiogenesis. Recent Publications highlight her work on: neurodevelopmental epigenetics (2023), HCAR1-mediated microglial activation (2022), mitochondrial dysfunction in metabolic disorders (2021), and long-standing expertise in oligodendrocyte physiology dating to 2007. Teaching includes courses in Molecular Medicine and Physiology (MED1100/MED2200) covering membrane transport, reproduction, and neuroenergetics. Research Groups : Active member of the Oligodendrocyte Group, contributing to projects on transplanted brain organoids and metabolic regulation in white matter.

Ashley BlackwellView profile

Assistant Professor

• Neuroscience
• Sensorimotor Integration
• Cognitive Aging
• +4 more

Ashley Blackwell, Ph.D. is an Assistant Professor in the Department of Psychology at the University of Nevada, Las Vegas (UNLV), where she leads research in the Behavioural Research and Integrative Neuroscience (BRaIN) Laboratory. Affiliated with UNLV's Interdisciplinary Neuroscience Program, her work bridges sensorimotor control, cognitive neuroscience, and translational disease modeling. Her research focuses on the neural basis of naturally occurring behaviors like reach-to-grasp movements and spatial navigation, analyzing how these processes are disrupted by space flight stressors (deep space radiation, sleep fragmentation), aging, and neuropathologies (stroke, Alzheimer's, alcohol exposure). Using behavioral assays, electrophysiology, histology, and computational modeling in both rodent and human studies, she develops sensitive translational assessments for early disease detection and treatment optimization. Analysis of her publications reveals key expertise in Galactic Cosmic Radiation (GCR) effects on cognition, fine motor control in disease models, sex-specific neurobiology , and stressor-induced deficits . Her NASA-funded work on spaceflight stressors in rodent models directly informs astronaut health risks during Mars missions. Scientific Awards: NASA Funding for Space Radiation Research Dr. Blackwell's lab emphasizes inclusion and diversity in neuroscience education while developing interventions against radiation-induced neurodegeneration. Her team's work on string-pulling tasks as behavioral assays has become central to understanding sensorimotor-cognitive interactions under extreme conditions.

• Neurodevelopment
• Inhibitory Synapse Formation
• Autism Spectrum Disorders
• +5 more

Rochelle Hines, Ph.D. , is an Associate Professor in the Department of Psychology at the University of Nevada, Las Vegas (UNLV). Her laboratory investigates how inhibitory synapses form, stabilize, and malfunction during brain development, with the overarching goal of identifying novel therapeutic avenues for autism, schizophrenia, and developmental epilepsies. Education Ph.D. in Neuroscience, University of British Columbia, Vancouver, Canada (2009) Postdoctoral Fellowship, Tufts University School of Medicine, Boston, MA (2015) Research Interests Dr. Hines’s research integrates molecular genetics, biochemistry, high-resolution microscopy, behavioral phenotyping, and electrophysiology to dissect the mechanisms governing inhibitory synapse maturation. By manipulating key synaptic proteins in mouse models, her team interrogates how disruptions in inhibitory signaling contribute to neurodevelopmental disorders. Core themes include: Molecular scaffolding of GABAergic synapses via collybistin and neuroligin-2 Functional specialization of GABA(A) receptor subunits in cortical and hippocampal circuits Translational biomarkers and therapeutic targets for epilepsy and autism Publication Trends Across 38 peer-reviewed articles since 2006, Dr. Hines’s work has progressed from fundamental discoveries in synaptic protein trafficking to preclinical evaluations of pharmacological modulators (e.g., TSPO ligands, micronized caffeine). Recent high-impact studies (2021–2025) emphasize multi-system analyses combining EEG, behavioral, and molecular readouts to bridge cellular mechanisms with circuit-level dysfunction. Laboratory & Collaborations The Hines Group at UNLV houses state-of-the-art facilities for confocal and electron microscopy, in vivo EEG/EMG recordings, and mouse behavioral testing. Active collaborations span Tufts University, University of British Columbia, and international consortia focused on neurodevelopmental genomics and bio-electronic therapeutics. Funding & Grants While specific grant identifiers are not listed, the consistent publication output and patent filings (e.g., therapeutic compounds for neurodevelopmental disorders, 2025) indicate sustained extramural funding from NIH, NSF, and private foundations.

Marie ArrietaView profile

Associate Professor

• Gut Microbiome
• Early-Life Immune Development
• Microbiome-Neurological Interactions
• +5 more

Dr. Marie Arrieta serves as Associate Professor in the Department of Physiology and Pharmacology at the Cumming School of Medicine, University of Calgary. She holds full membership in the Snyder Institute for Chronic Diseases and Inflammation Research Network, and serves as Child Health & Wellness Researcher at the Alberta Children's Hospital Research Institute. Her research program bridges clinical studies and experimental animal work to investigate gut microbiome interactions with infant development. Doctor of Philosophy in Experimental Medicine, University of Alberta (2011) M.Sc. in Physiology, University of Alberta (2005) B.Sc., University of Costa Rica (2001) Dr. Arrieta's research centers on early-life gut microbiome interactions with immune, metabolic, and neurological development. Her translational approach characterizes microbial dysbiosis associated with asthma, obesity, and stress dysregulation using birth cohort studies and mouse models. As a prominent science communicator, she authored the best-selling book Let Them Eat Dirt and contributes to documentary projects exploring microbiome science. She participates in three major university strategic initiatives: Brain and Mental Health (2015-2021), Child Health and Wellness (2020-2025), and Infections, Inflammations and Chronic Diseases (2015-2021). Analysis of her recent publications (2023-2025) reveals consistent focus on microbiome maturation trajectories, with particular emphasis on fungal-bacterial interactions (mycobiome), stress-axis perturbations, and metabolic programming. Her work increasingly examines inter-kingdom dynamics and behavioral outcomes, demonstrating evolution from foundational dysbiosis studies toward causal mechanisms and translational applications. Key trends include antibiotic impacts, maternal stress effects, and nutritional interventions targeting microbiome-mediated disease pathways. Dr. Arrieta actively mentors graduate students and postdoctoral fellows in the Arrieta Lab, which includes PhD candidates Fatimoh Kasaba and Emily Mercer, MSc student Kaetlyn Phillips, and multiple postdoctoral associates. Her research program receives substantial institutional support through university strategic initiatives and likely external funding from Canadian health research agencies, though specific grants aren't detailed in the profile. The Arrieta Lab maintains active collaborations across multiple research networks, including the BLOOM Clinical Study investigating early-life microbiome development. Lab operations include dedicated research staff managing gnotobiotic facilities for mouse studies and clinical sample processing for birth cohort analyses. Current projects focus on microbial transplantation, fungal-bacterial interactions, and microbiome-based interventions for developmental disorders.

• Biomedicine
• Neurosciences
• Genetics
• +4 more

Henna-Kaisa Wigren is a University Lecturer at the Molecular and Integrative Biosciences Research Programme within the Faculty of Biological and Environmental Sciences at the University of Helsinki. Her research focuses on the intersection of neurosciences , biomedicine , and physiology , with particular emphasis on sleep regulation and its neurobiological mechanisms. Biomedicine Neurosciences Genetics Developmental Biology Physiology Biochemistry Cell and Molecular Biology Over her career, Wigren has published extensively on topics including: Sleep-wake cycle regulation Microglial activity in sleep Neurochemical mechanisms of arousal Brain energy metabolism Comparative sleep research (including veterinary applications) Developmental neurobiology Her recent publications (2024-2025) focus on microglial morphology and pharmacological interventions in neuropathic pain-related sleep disturbances. Earlier works (2016-2020) examine anesthesia effects on brain proteomes, sleep homeostasis, and neurotrophic factor signaling. Scientific Recognition : 2010: Finnish Physiological Society Thesis Award Academic Contributions : Supervision of doctoral thesis (2022-present) Peer review for Physiology & Behavior , Behavioural Brain Research , and Neuroscience Letters Participation in international conferences (Society for Neuroscience, European Sleep Research Society) Collaborations in translational sleep research Current Projects : 2024-2025: Microglia in the sleeping brain.STS 25 (Finnish Society of Sciences and Letters) 2020-present: Sleepless in the stable (equine sleep disorders) 2011-2013: Aivoverkko (neuroscience network)

Eduardo Albornoz BalmacedaView profile

Research Fellow

• Neuroinflammation
• Neurodegenerative Diseases
• Immunology
• +4 more

Dr. Eduardo Albornoz Balmaceda is a Research Fellow at the School of Biomedical Sciences , The University of Queensland , specializing in neuroinflammation and neurodegenerative diseases. He completed his PhD in 2019 under Prof Matthew Cooper at the Institute for Molecular Biosciences, focusing on NLRP3 inflammasome inhibitors for Parkinson's disease. Currently, he extends this research in the Woodruff Lab , investigating peripheral innate immune responses in amyotrophic lateral sclerosis, Huntington's disease, and Parkinson's disease. Education: MSc in Biochemistry, Universidad Andrés Bello PhD in Neurosciences, The University of Queensland Research interests center on pharmacological targeting of inflammasomes and complement cascade components as therapeutic strategies for neuroinflammatory diseases. His work bridges neuroscience, immunology, and pharmacology, with a focus on SARS-CoV-2 neurotropism, microglial activation, and preclinical drug validation. Publications (17 journal articles, 8 conference papers) highlight his contributions to understanding C5a receptor signaling in Parkinson's disease, spike protein-mediated inflammasome activation in microglia, and maternal thyroid function's impact on offspring autoimmune responses. Supervision: Associate advisor for PhD on Huntington's disease Funding history includes grants from Motor Neurone Disease Research Institute of Australia and UniQuest Pty Ltd for projects like inflammatory biomarkers in Parkinson's disease and C9orf72 dipeptide targeting.

Teresa M. ReyesView profile

Researcher

• Neuroscience
• Neuroimmunology
• Developmental Neuroscience
• +4 more

Teresa M. Reyes is a Senior Research Associate at the University of Cincinnati College of Medicine, with affiliations at the Salk Institute of Biological Sciences and the University of Pennsylvania School of Medicine. She holds a PhD in Neuroscience from the University of Wisconsin–Madison and has over two decades of expertise in neuroimmunology, developmental neuroscience, and epigenetics. B.S., M.S., PhD in Neuroscience, University of Wisconsin–Madison Postdoctoral Fellowship, Salk Institute of Biological Sciences Her research focuses on how maternal nutrition, opioid exposure, and inflammation during pregnancy program offspring neurodevelopment, leading to sex-specific cognitive and behavioral deficits. She investigates mechanisms involving microglia, astrocytes, and epigenetic modifications in mouse models of childhood cancer, chemotherapy, and metabolic disorders. Key trends in her 15 most recent publications (2025–2021) include: microglial transcriptomic responses to perinatal opioid exposure; high-fat diet impacts on neuroinflammation and executive function; transcriptional profiling of astrocytes/microglia in cancer/chemotherapy models; and sex differences in neurodevelopmental disorders. Scientific Awards: NARSAD Young Investigator Award Grants & Collaborations: Multiple federal grants (NIH, NINDS, NIDDK) as PI Private funding from Burroughs Wellcome Fund and Rally Foundation

Agnes LuoView profile

Research Fellow

• Molecular Genetics
• Neuroinflammation
• Neuroprotection and Regeneration
• +2 more

Agnes Luo is a Research Fellow at the National Institute of Drug Abuse, NIH , with prior postdoctoral experience at the same institution. She holds a PhD in Molecular Toxicology from the University of Rochester and a Bachelor of Science in Environmental Biology from Nanjing University . Research Interests: Molecular Genetics, Neuroinflammation, Neuroprotection and Regeneration, Stem Cells and Regenerative Medicine, and Animal Models of Neurological Diseases. Her work focuses on neurodegenerative diseases, microglial functions, and therapeutic interventions for stroke and traumatic brain injury. Publication Trends: Recent articles explore microglia ablation models, Sonic Hedgehog signaling in neurogenesis, and p53's role in neurodegeneration. Key themes include neuroinflammatory mechanisms, neuroregenerative strategies, and molecular targets for neuroprotection. Contact Information: Email luoy2@ucmail.uc.edu at the Medical Sciences Building 2256.

Michael DaileyView profile

Associate Professor

• Neurobiology
• Cell and Developmental Biology
• Neuroinflammation
• +3 more

Michael Dailey is an Associate Professor at the University of Iowa, affiliated with the Department of Biology and Carver College of Medicine. He serves as Director of the Carver Center for Imaging (CCI) and leads a research laboratory focused on glial cell structure and function in mammalian brain development and pathology. PhD, Washington University (St. Louis) Research Interests Dr. Dailey’s work investigates microglial biology in brain development and injury response, with specific projects on: Purinergic signaling pathways regulating microglial activation Environmental toxicants (alcohol, pesticides) in neurodevelopmental disorders Microglial survival mechanisms in stroke models Neuroimmune interactions during developmental brain injury Advanced imaging techniques for live tissue analysis Recent Research Trends His 2025-2024 studies examine PCB exposure impacts on brain gene expression and maternal pesticide effects on fetal neurodevelopment. Earlier work from 2019-2013 explores alcohol-induced neuroinflammation, microglial dynamics in hippocampal injury, and imaging methodologies. Collaborations & Funding Dr. Dailey collaborates with Pediatrics and Neurology Departments (Carver College of Medicine) and Pharmacy/Public Health Colleges. His research on pesticide exposure receives funding from the National Institute for Environmental Health Sciences (NIEHS/NIH P30 ES005605). Laboratory The Dailey Lab (established 1996) specializes in time-lapse fluorescence imaging of rodent brain tissues to study neuronal-glial interactions, with strengths in confocal and multiphoton microscopy. The lab website provides further details on ongoing projects.

Jari Eerik KoistinahoView profile

Professor

• Neurosciences
• Neuroinflammation
• Alzheimer's Disease
• +6 more

Jari Eerik Koistinaho is a Professor at the University of Helsinki, affiliated with the Department of Pharmacology and Drug Therapy and serving as Director of the Helsinki Institute of Life Science (HiLIFE). He supervises the Doctoral Programme Brain & Mind and leads multiple international research projects. University of Helsinki Department of Pharmacology and Drug Therapy Helsinki Institute of Life Science (HiLIFE) His research focuses on neuroinflammation, neurodegenerative diseases, and microglial biology, with a particular emphasis on Alzheimer's disease and schizophrenia. Current projects investigate lysosomal dysfunction in microglia, genetic risk factors like APOE and PLCγ2 variants, and environmental neurotoxicity from diesel pollution. Recent projects funded by the Sigrid Jusélius Foundation (€252,000) and the European Commission Joint Research Centre explore amyloid-beta degradation mechanisms and synaptic plasticity in schizophrenia. His work spans molecular neuroscience, translational research, and environmental health impacts. EU Horizon Europe MSCA Postdoctoral Fellowship Sigrid Jusélius Foundation grant

• Neuroscience
• Neurophysiology
• Potassium Ion Dynamics
• +4 more

Andrea Grostøl Dietz is a Guest Researcher at the Center for Translational Neuromedicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research focuses on neuroscience, particularly examining potassium ion dynamics in the brain and their relationship to neural activity, behavior, and psychiatric conditions. Dr. Dietz's research interests span multiple areas of neuroscience including: Neurophysiology and brain state transitions Potassium ion dynamics in cortical networks Glial cell function in psychiatric disorders ADHD and psychopharmacology Development of biosensors for neuroimaging Extracellular ion homeostasis Her recent publications demonstrate a strong focus on understanding how extracellular potassium levels regulate neural network activity and behavior. She has made significant contributions to developing novel biosensors for in vivo potassium imaging and investigating the role of glial cells in schizophrenia pathophysiology. Her work bridges molecular neuroscience with clinical applications, particularly in understanding neurological and psychiatric conditions. Dr. Dietz has published in high-impact journals including PNAS, Cell Reports, Lancet Psychiatry, and PLOS Biology, indicating her work is well-regarded in the neuroscience community. Her research shows substantial media attention and citations, with one paper referenced in Wikipedia and picked up by multiple news outlets. She appears to collaborate extensively with prominent researchers in the field, including Maiken Nedergaard (a leading figure in glymphatic system research) and Hajime Hirase, suggesting strong integration within the neuroscience research community.